Compare PK & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PK | PAHC |
|---|---|---|
| Founded | 1946 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2014 | 2014 |
| Metric | PK | PAHC |
|---|---|---|
| Price | $10.42 | $55.40 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 3 |
| Target Price | $11.36 | ★ $34.33 |
| AVG Volume (30 Days) | ★ 3.2M | 229.4K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 9.74% | 0.95% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | ★ $2,791,000,000.00 | $833,350,000.00 |
| Revenue This Year | $2.44 | $17.03 |
| Revenue Next Year | $2.49 | $3.82 |
| P/E Ratio | ★ N/A | $38.56 |
| Revenue Growth | 2.35 | ★ 4.12 |
| 52 Week Low | $8.27 | $16.16 |
| 52 Week High | $12.39 | $56.30 |
| Indicator | PK | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 63.75 |
| Support Level | $10.01 | $37.09 |
| Resistance Level | $10.97 | $56.14 |
| Average True Range (ATR) | 0.34 | 2.48 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 21.66 | 98.05 |
Park Hotels & Resorts owns upper-upscale and luxury hotels, with 22,395 rooms across 36 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.